Moteur de recherche d’entreprises européennes
Financement de l’UE (3 316 013 €) : Fièvre hémorragique virale : approches modernes pour le développement d’un diagnostic rapide au chevet du patient Hor01/01/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Fièvre hémorragique virale : approches modernes pour le développement d’un diagnostic rapide au chevet du patient
VHFMoDRAD will develop and deliver rapid and point-of-care singel/multiplex diagnostic tool(s) that will significantly increase our capacity to handle outbreaks with Filoviruses and other viral hemorrhagic fever diseases in Africa. The overall aim of VHFMoDRAD is to carry on the outcome of the currently running EbolaMoDRAD project to the next level, which is behind of the scope of that project. The goals of VHFMoDRAD will be done via a multidisciplinary research consortium drawn from key European and African research organisations and also industry and SMEs, thus consolidating previous tools and knowledge. VHFMoDRAD will also put in place a strong capacity building programme in West Africa The project will disseminate widely all results as they become available, notably to public health bodies and non-governmental organisations (NGOs), via a strong outreach programme. To achieve this overall aim an intensive work plan will be put in place, with the following specific objectives: - to develop rapid molecular and serological single/multiplex detection methods; - perform preclinical validation of diagnostic tools; - to validate the successful diagnosis tools under field conditions; - implement a strong capacity building programme in West Africa by a twining program; - to exploit results; - to disseminate the results to public health bodies, NGOs, outbreak management teams and local hospitals in West Africa.
| Biotech Investissement | 0,00 € |
| Cepheid Europe | 0,00 € |
| Coris Bioconcept SPRL | 372 822 € |
| Department of Health | 102 286 € |
| Emergency Life Support FOR Civilian WAR Victims ONG Onlus | 5 439,99 € |
| Folkhalsomyndigheten | 380 506 € |
| Inserm Transfert SA | 245 250 € |
| Institut de Recherche Pour le Developpement | 0,00 € |
| Institut National de la Sante et de la Recherche Medicale | 550 326 € |
| Institut Pasteur DE Dakar | 185 250 € |
| Istituto Nazionale Per LE Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico | 55 763 € |
| Kobenhavns Universitet | 151 695 € |
| Medizinische Hochschule Brandenburg Campus GmbH | 191 581 € |
| RD-Biotech | 204 550 € |
| Sivas Cumhuriyet Universitesi | 25 000 € |
| The University of Stirling | 143 324 € |
| Universite d'AIX Marseille | 702 219 € |
https://cordis.europa.eu/project/id/823666
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.